1,708.60p+3.40 (+0.20%)28 Mar 2024, 18:59
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Gsk PLC Market & Company News

02.02.2023 07:00GSKDaprodustat approved by US FDA for anaemia of CKDRNS
01.02.2023 15:30GSKDirector/PDMR ShareholdingRNS
01.02.2023 15:00GSKTotal Voting RightsRNS
01.02.2023 09:09HLN, GSKTOP NEWS: GSK profit grows as aims for first-ever approved RSV vaccineAlliance
01.02.2023 07:05GSKBenlysta granted Orphan Drug Designation by US FDARNS
01.02.2023 07:00GSKFinal ResultsRNS
31.01.2023 12:54GSK, HLNHaleon appoints Pfizer Chief Financial Officer David Denton to boardAlliance
25.01.2023 15:45VOD, VMUK, UKCMUK earnings, trading statements calendar - next 7 daysAlliance
18.01.2023 15:30GSKDirector/PDMR ShareholdingRNS
18.01.2023 11:10IPO, GSKIN BRIEF: IP Group appoints GSK's Anita Kidgell as non-executive Alliance
17.01.2023 15:30GSKDirector/PDMR ShareholdingRNS
16.01.2023 15:30GSKDirector/PDMR ShareholdingRNS
13.01.2023 15:30GSKDirector/PDMR ShareholdingRNS
12.01.2023 15:30GSKDirector/PDMR ShareholdingRNS
05.01.2023 15:41TRY, SSE, SNWSUK dividends calendar - next 7 daysAlliance
05.01.2023 09:05GSKIN BRIEF: WuXi Biologics signs exclusive deal with GSK Alliance
03.01.2023 15:00GSKTotal Voting RightsRNS
03.01.2023 09:24DRX, HIK, WIZZLONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRHAlliance
22.12.2022 15:30GSKDirector/PDMR ShareholdingRNS
21.12.2022 15:35GSKDirector/PDMR ShareholdingRNS
21.12.2022 15:30GSKDirector/PDMR ShareholdingRNS
15.12.2022 15:30GSKBoard and Committee ChangesRNS
13.12.2022 15:30GSKDirector/PDMR ShareholdingRNS
08.12.2022 09:48TTG, XPP, VLXLONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAGAlliance
07.12.2022 07:00GSKStatement: Zantac (ranitidine) litigationRNS
06.12.2022 21:59HLN, GSKTOP NEWS: GSK welcomes Zantac legal boost in FloridaAlliance
05.12.2022 16:00GSKTransfer of Treasury SharesRNS
05.12.2022 10:00WJG, AIBG, FERGLONDON BROKER RATINGS: Jefferies cuts Persimmon; BoA cuts GSKAlliance
02.12.2022 15:30GSKDirector/PDMR ShareholdingRNS
02.12.2022 09:38ROO, JET, THGLONDON BROKER RATINGS: Jefferies raises AJ Bell to 'buy' from 'hold'Alliance
02.12.2022 08:47GSKTOP NEWS: GSK gets EMA validation for bone marrow cancer treatmentAlliance
02.12.2022 07:00GSKEMA file accepted for momelotinibRNS
02.12.2022 07:00GSKJemperli positive trial in endometrial cancerRNS
01.12.2022 15:00GSKTotal Voting RightsRNS
25.11.2022 16:47GSKPublication of Final Terms of EMTN NotesRNS
24.11.2022 15:00GSKGSK publishes provisional 2023 dividend datesRNS
22.11.2022 16:00GSKPublication of Supplementary EMTN ProspectusRNS
22.11.2022 08:41GSKTOP NEWS: GSK suffers setback as FDA demands withdrawal of cancer drugAlliance
22.11.2022 07:00GSKBlenrep US UpdateRNS
21.11.2022 15:30GSKDirector/PDMR ShareholdingRNS
18.11.2022 16:00GSKPublication of EMTN Supplementary ProspectusRNS
15.11.2022 16:00GSKBlock listing Interim ReviewRNS
15.11.2022 15:53GSKFinal results of outstanding Notes Tender OfferRNS
15.11.2022 09:58AMS, RWI, ITMLONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'Alliance
15.11.2022 07:00GSKInterim results of outstanding Notes Tender OfferRNS
11.11.2022 10:44GSKGSK to restrict US use of cancer drug Zejula to some populations Alliance
11.11.2022 07:00GSKGSK Update: Zejula 2L in USRNS
10.11.2022 18:10GSKSanofi-GSK COVID booster vaccine approved by EURNS
10.11.2022 15:54YNGA, VLX, GSEOUK dividends calendar - next 7 daysAlliance
10.11.2022 15:30GSKDirector/PDMR ShareholdingRNS
10.11.2022 09:00GSKBlock Listing ApplicationRNS
08.11.2022 09:39AFM, ITM, WIZZLONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises HammersonAlliance
08.11.2022 09:26GSKLaunch of Tender Offer for outstanding NotesRNS
07.11.2022 08:59GSKGSK looks to combination trials as cancer drug fails to meet endpointAlliance
07.11.2022 07:00GSKDREAMM-3 phase III trial for BlenrepRNS
04.11.2022 08:08GSK, AZNTOP NEWS: AstraZeneca's Beyfortus wins EU approval for RSV in newbornsAlliance
03.11.2022 13:00GSKPublication of Suppl.ProspctsRNS
03.11.2022 09:13GSKGSK halts enrolment early for UTI trials; moves to regulatory approvalAlliance
03.11.2022 07:00GSKIDMC recommends gepotidacin early efficacy stopRNS
02.11.2022 09:26HLN, GSKTOP NEWS: GSK ups annual guidance on "excellent" quarterly performanceAlliance
02.11.2022 07:01GSK3rd Quarter ResultsRNS
02.11.2022 07:00GSKGSK RSV vaccine: US FDA Priority ReviewRNS
01.11.2022 15:00GSKTotal Voting RightsRNS
31.10.2022 14:28GSK, HLNHaleon announces results for exchange offers from GSK spin-offAlliance
28.10.2022 08:44GSKTOP NEWS: GSK gets support from European panel for HIV prevention Alliance
28.10.2022 07:00GSKEMA validates MAA for cabotegravir LA for PrEPRNS
28.10.2022 07:00GSKEMA accepts GSK RSV older adult vaccine for reviewRNS
27.10.2022 10:02GSKUS FDA advisory panel votes against GSK kidney drug use in some casesAlliance
27.10.2022 07:05GSKGSK announces FDA meeting outcome on daprodustatRNS
27.10.2022 07:00GSKContRAst phase III programme for otilimab updateRNS
26.10.2022 15:53WIZZ, WEIR, SKGUK earnings, trading statements calendar - next 7 daysAlliance
25.10.2022 10:00GSKBoard Committee ChangesRNS
24.10.2022 10:28GSK, SARIN BRIEF: Sareum widens annual loss; considers future of SRA737Alliance
21.10.2022 09:10GSKGSK says respiratory vaccine candidate accepted for review in JapanAlliance
21.10.2022 07:00GSKRSV older adult vaccine submission in JapanRNS
Showing 301 to 375 of 805